Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.

Despite readily detectable virus-specific CD8(+) T cells in most HIV-infected patients, immune surveillance is eventually lost, leading to progression to AIDS. Recently developed insights into human T-cell differentiation have been used to study the phenotype of virus-specific T cells in HIV-infected individuals. Based on these results, we propose that failing immune control in human viral infection could be a result of impaired cytotoxic T-lymphocyte (CTL) maturation into fully differentiated effector T cells. Impaired maturation is not confined to HIV-specific CD8(+) T cells but could also be involved in failing immunity to Epstein-Barr virus and other viral infections. We postulate that CD27(-) effector CD8(+) T cells might be required for adequate control of chronic viral infection and prevention of disease development.

[1]  C. Rinaldo,et al.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.

[2]  M. Salmon,et al.  Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. , 2002, Blood.

[3]  P. Klenerman,et al.  HIV: current opinion in escapology. , 2002, Current opinion in microbiology.

[4]  R. Zinkernagel,et al.  Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.

[5]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[6]  T. Schumacher,et al.  Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. , 2001, Blood.

[7]  S. Landolfo,et al.  Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection , 2000, European journal of immunology.

[8]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[9]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[10]  P. Romero,et al.  Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. , 2001, Cancer research.

[11]  Douglas D. Richman,et al.  HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function , 2000, The Journal of experimental medicine.

[12]  J. Lieberman,et al.  CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. , 2001, Blood.

[13]  A. Rickinson,et al.  Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection , 2002, The Journal of experimental medicine.

[14]  D. Speiser,et al.  Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. , 1999, Cancer research.

[15]  M. Takiguchi,et al.  Differentiation of Human CD8+ T Cells from a Memory to Memory/Effector Phenotype1 , 2002, The Journal of Immunology.

[16]  T. Greten,et al.  Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. , 2001, The Journal of infectious diseases.

[17]  M. V. von Herrath,et al.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge , 1996, Journal of virology.

[18]  P. Doherty,et al.  Accessing complexity: the dynamics of virus-specific T cell responses. , 2000, Annual review of immunology.

[19]  A. Harris,et al.  A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1 , 2000, The Journal of Immunology.

[20]  S. Kostense,et al.  Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression , 1999, Journal of Virology.

[21]  P. Doherty,et al.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. , 1997, Journal of immunology.

[22]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[23]  J. Bell,et al.  Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.

[24]  L. Lanier,et al.  CD28- T lymphocytes. Antigenic and functional properties. , 1993, Journal of immunology.

[25]  J. Lieberman,et al.  Avoiding the kiss of death: how HIV and other chronic viruses survive. , 2002, Current opinion in immunology.

[26]  Stefan Kostense,et al.  High viral burden in the presence of major HIV‐specific CD8+ T cell expansions: evidence for impaired CTL effector function , 2001, European journal of immunology.

[27]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[28]  M. Catalina,et al.  Phenotypic and Functional Heterogeneity of EBV Epitope-Specific CD8+ T Cells1 , 2002, The Journal of Immunology.

[29]  S. Kostense,et al.  Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection , 2002, AIDS.

[30]  D. Baarle,et al.  Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans. , 2000, The Journal of infectious diseases.

[31]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[32]  E. Wherry,et al.  Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells , 2002, The Journal of experimental medicine.

[33]  R. V. van Lier,et al.  Regulation of CD27 expression on subsets of mature T-lymphocytes. , 1993, Journal of immunology.

[34]  D. Nixon,et al.  High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. , 2000, The Journal of infectious diseases.

[35]  M. Weekes,et al.  Identification of Naive or Antigen-Experienced Human CD8+ T Cells by Expression of Costimulation and Chemokine Receptors: Analysis of the Human Cytomegalovirus-Specific CD8+ T Cell Response1 , 2002, The Journal of Immunology.

[36]  S. Kostense,et al.  Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. , 1999, International immunology.

[37]  G. Ogg,et al.  Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.

[38]  D. van Baarle,et al.  Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. , 2002, The Journal of infectious diseases.

[39]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[40]  Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. , 2002, Blood.

[41]  D. Srivastava,et al.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.

[42]  D. Brooks,et al.  Critical Role for CD4+ T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice , 1998, Journal of Virology.

[43]  R. V. van Lier,et al.  Faces and phases of human CD8 T-cell development. , 1999, Immunology today.

[44]  Dominik Wodarz,et al.  The importance of lytic and nonlytic immune responses in viral infections. , 2002, Trends in immunology.

[45]  P. Doherty,et al.  Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells , 1996, The Journal of experimental medicine.

[46]  Mario Roederer,et al.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.

[47]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[48]  H. Schuitemaker,et al.  Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. , 1998, The Journal of infectious diseases.

[49]  D. Baarle,et al.  Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. , 2001, Blood.

[50]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[51]  M. Kersten,et al.  Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. , 1997, The Journal of clinical investigation.

[52]  H. Schuitemaker,et al.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.

[53]  M. Salmon,et al.  EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function1 , 2001, The Journal of Immunology.